WallStreetZenWallStreetZen

NASDAQ: ANL
Adlai Nortye Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ANL stock forecasts and price targets.

Forecast return on equity

Is ANL forecast to generate an efficient return?
Company
-335.99%
Industry
24.97%
Market
11.38%
ANL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANL forecast to generate an efficient return on assets?
Company
-204.92%
Industry
4.5%
ANL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANL earnings per share forecast

What is ANL's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$2.41

ANL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANL$3.41N/AN/A
BLUE$1.15$3.43+197.83%Hold
XFOR$0.75$5.00+568.45%Strong Buy
ANVS$11.39$33.00+189.73%Strong Buy
DMAC$3.26$7.00+114.72%Buy

Adlai Nortye Stock Forecast FAQ

What is ANL's earnings growth forecast for 2024-2024?

(NASDAQ: ANL) Adlai Nortye's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Adlai Nortye's earnings in 2024 is -$104,871,000.

In 2024, ANL is forecast to generate -$266,788,940 in earnings, with the lowest earnings forecast at -$266,788,940 and the highest earnings forecast at -$266,788,940.

If you're new to stock investing, here's how to buy Adlai Nortye stock.

What is ANL's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: ANL) forecast ROE is -335.99%, which is considered weak.

What is ANL's Earnings Per Share (EPS) forecast for 2024-2024?

(NASDAQ: ANL) Adlai Nortye's current Earnings Per Share (EPS) is -$7.26. In 2024, ANL's EPS is forecast to hit -$2.41 (min: -$2.41, max: -$2.41).

What is ANL's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: ANL) forecast ROA is -204.92%, which is lower than the forecast US Biotechnology industry average of 4.5%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.